With $175m, Mariana Will Take First Precision Radiopharmaceutical Into The Clinic
Firm Raised $75m Series A In Late 2021 As Curie
Mariana Oncology closed a $175m series B venture capital round to fund its first clinical trial, for MC-339 in small-cell lung cancer, as well as its manufacturing and pipeline-building activities.
